CSPC Pharmaceutical Group Limited (HKG:1093)
8.33
-0.37 (-4.25%)
Oct 22, 2026, 3:40 PM HKT
CSPC Pharmaceutical Group Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, CSPC Pharmaceutical Group stock has a consensus rating of "Buy" and an average price target of $12.67. The average 1-year stock price forecast is 52.10% higher than the current stock price, while the lowest is $8.00 (-3.96%) and the highest is $19.36 (+132.41%).
Price Target: $12.67 (+52.10%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 9, 2026.
Analyst Ratings
The average analyst rating for CSPC Pharmaceutical Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 14 | 14 | 17 | 17 | 17 |
| Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Hold | 3 | 2 | 2 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 3 | 3 | 3 | 1 | 1 | 1 |
| Total | 24 | 23 | 23 | 23 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DBS | DBS | Buy Initiates $13.70 | Buy | Initiates | $13.70 | +64.47% | Sep 9, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $10.90 → $11.80 | Buy | Maintains | $10.90 → $11.80 | +41.66% | Aug 27, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $18.00 | Buy | Maintains | $18.00 | +116.09% | Aug 25, 2026 |
| Jefferies | Jefferies | Sell Maintains $8.00 | Sell | Maintains | $8.00 | -3.96% | Aug 24, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $19.36 | Buy | Maintains | $19.36 | +132.41% | Aug 22, 2026 |
Financial Forecast
Revenue This Year
33.88B
from 26.01B
Increased by 30.29%
Revenue Next Year
31.43B
from 33.88B
Decreased by -7.25%
EPS This Year
0.79
from 0.31
Increased by 154.79%
EPS Next Year
0.59
from 0.79
Decreased by -25.34%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.